APA (7th ed.) Citation

Copil, F., Campani, C., Lequoy, M., Sultanik, P., Blaise, L., Wagner, M., . . . Allaire, M. (2024). No correlation between MASLD and poor outcome of Atezolizumab‐Bevacizumab therapy in patients with advanced HCC. Liver International, 44(4), 931. https://doi.org/10.1111/liv.15833

Chicago Style (17th ed.) Citation

Copil, Francisca‐Dora, et al. "No Correlation Between MASLD and Poor Outcome of Atezolizumab‐Bevacizumab Therapy in Patients with Advanced HCC." Liver International 44, no. 4 (2024): 931. https://doi.org/10.1111/liv.15833.

MLA (9th ed.) Citation

Copil, Francisca‐Dora, et al. "No Correlation Between MASLD and Poor Outcome of Atezolizumab‐Bevacizumab Therapy in Patients with Advanced HCC." Liver International, vol. 44, no. 4, 2024, p. 931, https://doi.org/10.1111/liv.15833.